CRISPR Technology Explored in Oncology
Dr. Lynch Discusses Challenges Associated With Molecular Targeted Therapies in Lung Cancer
Choosing Chemotherapy for Pancreatic Cancer
Dr Burke Pinpoints Top Trends from ASH 2024
Prognosis and Treatment of Follicular Lymphoma
Transform Cancer Care Management with Multimodal AI Agents | OD815
Dr. Gordon J. Freeman on Toxicities Associated With Immunotherapies
Diagnosis of Metastatic Platinum-Resistant Ovarian Cancer
Options in Breast Cancer After HER2+ Targeted Therapy
Advances in Urologic Oncology and the Evolving Role of the Surgeon
Outcomes in RRMM: The Modern Treatment Paradigm and BCMA
Systemic Therapy and Future of GEJ Cancer Treatment
Dr. Tempero on Immunotherapy Agents in Pancreatic Cancer
Dr. Brufsky Discusses Adjuvant Bisphosphonates as a New Standard of Care
Evolving Role of HER2-Targeted Therapy in Breast Cancer
Multidisciplinary Approach Helps Determine Best Setting for Surgery in Metastatic Breast Cancer
Testing for BRCA and HRD in Ovarian Cancer
Comorbidities and Rituximab-Based Therapy in FL
The Future of CAR T-Cell Therapy: Insights From ASCO GI and EHA/EBMT